Next Article in Journal
Factor Structure of the GHQ-12 and Their Applicability to Epilepsy Patients for Screening Mental Health Problems
Previous Article in Journal
Effectiveness of Exercise, Cognitive Behavioral Therapy, and Pharmacotherapy on Improving Sleep in Adults with Chronic Insomnia: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Effectiveness of a Health Education Program in Hypertensive Patients with Dyslipidemia and/or Microalbuminuria: A Quasi-Experimental Study in Vinh Long Province, Vietnam

1
Department of Epidemiology, Can Tho University of Medicine and Pharmacy, Can Tho 900000, Vietnam
2
Department of Physiology, Faculty of Medicine, Can Tho University of Medicine and Pharmacy, Can Tho 900000, Vietnam
3
Department of Nutrition and Food Safety, Can Tho University of Medicine and Pharmacy, Can Tho 900000, Vietnam
4
Department of Health Organization and Management, Can Tho University of Medicine and Pharmacy, Can Tho 900000, Vietnam
*
Authors to whom correspondence should be addressed.
Healthcare 2023, 11(15), 2208; https://doi.org/10.3390/healthcare11152208
Submission received: 19 June 2023 / Revised: 25 July 2023 / Accepted: 3 August 2023 / Published: 4 August 2023
(This article belongs to the Section Community Care)

Abstract

:
Introduction: Hypertension, a major health concern, is associated with significant mortality and disease burden worldwide, including Vietnam. Comprehensive interventions targeting medication, lifestyle modifications, dyslipidemia (DLP), and microalbuminuria (MAU) are vital for effective hypertension management and reducing the risk of cardiovascular disease complications (CDV). While medication interventions have proven efficacy, the evidence regarding the effectiveness of community-based health education interventions in managing DLP and MAU is limited. Therefore, this study aims to evaluate the effectiveness of community health education interventions in reducing hypertension risk factors and achieving hypertension management objectives, as well as managing DLP and MAU among hypertension patients. Methods: A quasi-experimental study was conducted on 330 hypertensive patients with dyslipidemia (DLP) and/or microalbuminuria (MAU) who were divided into a control group (n = 164) and an intervention group (n = 166). The control group received standard national hypertension management, while the intervention group received additional intensive health education provided by trained volunteers. The effectiveness of the intervention was assessed by comparing outcomes such as lifestyle factors, BMI control, treatment adherence, hypertension control, and DLP and MAU status between the two groups before and after a two-year intervention period. Results: The health education intervention resulted in significant reductions in dietary risk factors, specifically in fruit and vegetable consumption (p < 0.001). There was a lower prevalence of high salt intake in the intervention group compared to the control group (p = 0.002), while no significant differences were observed in other dietary factors. Smoking habits and low physical activity significantly decreased in the intervention group, with a notable disparity in physical activity proportions (p < 0.001). Both groups showed significant improvements in achieving hypertension management targets, with the intervention group demonstrating superior outcomes. The intervention was effective in reducing the prevalence of risk factors, particularly treatment non-adherence, blood pressure control, and low physical activity. Additionally, the intervention group had a higher likelihood of achieving DLP and MAU control compared to the control group. Conclusions: This study underscored the additional positive impact of incorporating health education by non-professional educators in achieving favorable outcomes, including better control of BMI, blood pressure, medication adherence, and management of dyslipidemia (DLP) and microalbuminuria (MAU). Further research is warranted to fully explore the potential of health education in primary healthcare settings and maximize its effectiveness.

1. Introduction

Hypertension carries significant importance within the realm of global health, given its profound impacts and repercussions. It is estimated to contribute to 7.5 million deaths worldwide, accounting for approximately 12.8% of total global mortality. Furthermore, hypertension adds to the disease burden, accounting for 57 million DALYs (3.7% of global DALYs) [1]. Among adults in low- and middle-income countries (LMICs), the prevalence of hypertension is 31.1%, with a treatment rate of 44.5%, and only 17.9% achieving optimal blood pressure control [2]. Notably, in Vietnam, the prevalence of hypertension among adults aged 18 and older was recorded at 47.3% [3]. Pharmacological and non-pharmacological interventions are recommended to address hypertension and associated cardiovascular disease (CVD) complications [4,5].
Several important aspects that deserve attention in hypertension management are the prevention and management of complications associated with cardiovascular disease (CVD). Firstly, an elevated risk for CVD complications is posed by the presence of dyslipidemia (DLP) and/or microalbuminuria (MAU) in combination with hypertension [6,7,8]. Addressing these conditions with medication intervention is well-documented. In the case of dyslipidemia, several reviews on medication approaches highlighted the efficacy of pharmacological interventions [9,10]. Likewise, successful MAU management with medication was proved in some trials [11,12]. Considering DLP and MAU management as part of comprehensive management strategies for hypertension, healthcare professionals can mitigate the risk of CVD complications and improve patient outcomes.
In addition to medication, lifestyle modifications are recommended for controlling blood pressure and managing DLP and MAU [13,14]. Nevertheless, the evidence regarding their efficacy in addressing DLP and MAU in a community setting is scarce. Few studies have been able to provide substantial evidence regarding the effectiveness of interventions in achieving their goals [15,16,17]. There is also limited evidence regarding the effectiveness of community health education in promoting lifestyle modifications for DLP and MAU management purposes. This research aimed to assess the effectiveness of community health education interventions in reducing hypertension risk factors and managing hypertension objectives, DLP, and MAU among patients. The results of this study might provide insight for policy makers in terms of implementing mass health education programs.

2. Methods

2.1. Study Design

A quasi-experimental study was conducted on a total of 330 hypertensive patients with DLP and/or with MAU. These patients were randomly selected from the hypertensive patient management list of commune clinics in two districts of Vinh Long province, Vietnam. They were then allocated into two groups: a control group consisting of 164 patients and an intervention group consisting of 166 patients. The control group (164 patients) received the standard national hypertension management program, while the intervention group (166 patients) received the same program supplemented with an intensive health education program delivered by trained volunteers during the two-year intervention period. The effectiveness of the intervention was assessed by comparing the rates of outcomes including lifestyle factors, BMI control, treatment adherence, hypertension control, and DLP and MAU status between the two groups before and after the 2-year intervention, from December 2016 to December 2018.

2.2. Setting

In Vietnam’s national strategy for noncommunicable disease prevention and control until 2025, holistic measures address cardiovascular diseases and hypertension. These include activities focused on leadership, policy implementation, and coordination among relevant departments and agencies. Efforts strengthen the capacity of healthcare facilities and personnel in preventing, detecting, managing, treating, and caring for cardiovascular diseases and hypertension. Specialized programs and plans address tobacco and alcohol harms and promote physical activity at the commune level, the lowest administrative divisions in Vietnam. Salt reduction campaigns are also implemented to prevent hypertension and stroke. For instance, the program targets individuals aged forty and above with a considerable risk of hypertension. Population screening identifies high blood pressure, ensures medication coverage through health insurance at the commune level, and provides hypertension prevention education led by lay health workers [18]. Those measures are currently implemented in both districts of this study.

2.3. Sampling

The sampling process in this study involved multiple stages, including randomization and systematic random sampling techniques, and was conducted in Vinh Long province. Firstly, two districts, Binh Minh and Mang Thit, were randomly selected from a population of eight districts in Vinh Long province. Within each of the selected districts, four wards were randomly chosen. The sampling frame for this study consisted of the hypertensive patient management list from the respective wards, comprising a total of 778 patients. From this sampling frame, all patients with DLP and/or MAU were identified based on their health records. These selected patients formed the eligible pool for inclusion in the study. Then, utilizing a systematic random sampling approach resulted in 170 patients for each arm of the study in the sampling section. Within each of the four selected wards, around 40 patients with DLP and/or MAU were systematically chosen from the sampling frame. Moreover, patients from the Binh Minh district were assigned to the intervention group, while patients from the Mang Thit district were assigned to the control group. This assignment aimed to examine the effectiveness of the intervention on the outcome variables, comparing it to the control condition.
Participants met the study’s inclusion criteria for hypertension diagnosis based on the European Society of Hypertension guidelines: systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg, or current use of antihypertensive medication, with evidence of current DLP and/or MAU [19]. Participants needed to have at least six months of residency in Vinh Long province and provide informed consent to be included in the study.
Exclusion criteria encompassed individuals who relocated during the study, those with communication impairments from psychiatric disorders, severe mobility limitations, end-stage renal disease, pregnant women with hypertension, and individuals with a history of myocardial infarction or stroke. The loss to follow-up rates were 3.5% (6 out of 170) in the intervention group and 2.35% (4 out of 170) in the control group. These rates, below the accepted threshold of 5%, suggest minimal potential for bias due to loss to follow-up, although it cannot be excluded [20].

2.4. Measurements

Baseline data, including age, gender, educational level, marital status, health insurance status, and time of hypertension diagnosis, were collected by trained interviewers. Additionally, in this research, various measurements were taken to assess the effectiveness of the intervention. They were primary and secondary outcomes measured both before and after the intervention. Secondary outcomes were lifestyle risk factors and treatment objectives at baseline time and after the two-year period. Firstly, the risky lifestyle habits included low consumption of vegetables (under 400 g/day), high salt intake (greater than 3 days/week), high consumption of fried or processed foods (greater than 3 days/week), high alcohol consumption with over 5 drinks/week for men and 2 drinks/week for women (yes/no), low physical activity level with under 150 min of moderate physical activity/week (yes/no), and tobacco smoking habits (yes/no). These outcomes were measured by self-reporting questions. Secondly, weight control (BMI < 23), adherence to treatment protocols (Morisky—8 questions adherence score <2), and blood pressure control (systolic BP < 140 mmHg and diastolic BP < 90 mmHg) were other important secondary outcomes, which served as objectives of hypertension management. The primary outcome in this intervention research pertained to lipid profile control (Yes/No) and MAU status (Yes/No). Achieving DLP (Yes) was determined by meeting specific criteria for all of the four lipid components: total cholesterol < 5.2 mmol/L, triglyceride < 1.7 mmol/L, LDL-C < 3.4 mmol/L, and HDL-C ≥ 1 mmol/L. If any of these components did not meet the desired targets, the participant was considered as not achieving DLP (No). MAU control was assessed based on the albumin-to-creatinine ratio (ACR) being below 30. On the other hand, achieving MAU control (Yes) was determined by attaining an albumin-to-creatinine ratio (ACR) below 30, while patients with ACR > 30 were considered not achieving the target (No).
The test procedure of each patient was performed by commune clinic nurses collaborating with the laboratory department of Can Tho University of Medicine and Pharmacy. To calculate the cost-effectiveness of the intervention, the Incremental Cost-Effectiveness Ratio (ICER) was used. Based on the formula for ICER, the cost difference between the two groups was the additional cost incurred for the health education activities. The direct costs include payments for the intervention team, health education activities, training activities, and management payments to the healthcare station. The indirect costs are assumed to be the same between the two groups.

2.5. Data Analysis

Epidata software was used for data entry, and SPSS software was used for data analysis on 164 patients in the intervention group and 166 patients in the control group. Frequency distributions were utilized to describe the sociodemographic characteristics of both the intervention and control groups. At baseline, homogeneity between the two groups across demographic variables, lifestyle factors related to hypertension, and hypertension history was assessed using chi-square tests. Similarly, the chi-square test was employed to compare the differences in secondary and primary outcomes between the control and intervention groups prior to the intervention. A significance level of 0.05 was used for all tests to establish statistical significance. The effectiveness of the intervention was measured both within groups and between groups. Within each group, the McNemar test was employed to assess the differences in all outcomes before and after the intervention. The chi-square test was utilized to assess the differences between the intervention group and the control group after the intervention. The effectiveness of the intervention was evaluated by assessing changes within each group before and after the intervention, as well as differences observed between the groups after the intervention. Moreover, to estimate the effectiveness of dependent intervention in terms of mitigating risk factors, absolute risk reduction (ARR) was also calculated. The number needed to treat (NNT) was calculated to quantify effectiveness by determining the number of patients needed to receive the intervention for risk factor reduction in one patient. The difference between groups was measured for each specific outcome in terms of risk behaviors and treatment goals, such as achieving blood pressure, DP, and MAU targets. Since multiple outcomes were measured, the total cost was assumed to be evenly distributed among the different outcomes, and the ICER was calculated accordingly.

2.6. Intervention

Health education for managing DLP and/or MAU in hypertension followed key principles: community-based implementation, addressing healthcare needs, minimizing monetary impact, ensuring simplicity and consistency, aligning with local conditions, and providing clear information.
Initially, based on baseline lipid profile tests, patients in both groups were informed about their condition and advised on treatment options at a medical station or a preferred location of their choice. Each patient in intervention groups was introduced to the health education activities provided by a volunteer team for the next 2 years.
In each selected ward, the intervention team consisted of volunteer students in public health and preventive medicine, along with a local primary care physician. The trained students conducted health education sessions for patients and their families in the intervention group, supported by a primary physician from each commune health station. The team received counseling support for health education activities from supervisors and faculty members at Can Tho University of Medicine and Pharmacy.
Two voluntary students were assigned to each ward, with approximately forty patients. They conducted group health education sessions at community centers or suitable venues in January, March, June, and December of the first year. During the sessions, volunteers provided additional guidance to hypertensive patients regarding non-pharmacological treatment measures, including smoking cessation, alcohol reduction, balanced diet, weight management, treatment adherence, and regular blood pressure monitoring.
Additionally, the team also conducted monthly household visits to support and monitor patients and their family members. Each patient was individually assigned specific targets tailored to their current lifestyle and hypertension condition. Health education objectives were tailored to each patient’s needs, covering medication adherence, physical activity, diet, weight management, and blood pressure control. Family members were provided with educational materials to support and remind patients to follow recommendations. During subsequent household visits, the team concentrated on addressing any unmet targets by collaboratively fostering feasible health behaviors for individuals with hypertension. This approach aimed to help patients gradually achieve their desired outcomes.
The health education content aimed to empower hypertensives to actively manage their blood pressure and make positive lifestyle changes by providing concise and easily understandable knowledge and instructions. The content emphasized risks, smoking and alcohol impact, dietary guidelines, and physical activity’s significance for hypertension control. Local terminology and examples were used to enhance comprehension and implementation.

3. Results

3.1. Groups Comparison

To assess group homogeneity at baseline, a chi-square test examined demographic characteristics, medical records, lifestyle factors, hypertension management, and DLP and MAU status.
The study found a higher proportion of females than males in both groups (59.1% in the intervention group, 62.7% in the control group). The most common age group was 60–69 years, comprising 47% in the intervention group and 50% in the control group. Notably, primary education was the highest educational level, comprising over 40% in both groups. The results of the chi-square test indicated a similarity in sociodemographic characteristics, including gender, age, ethnicity, and education level, between the intervention and control groups (p > 0.4) (Table 1). Likewise, the study found no significant differences between both groups in terms of duration of hypertension and comorbidities with all p-values greater than 0.3 (Table 2). In both groups, most patients, accounting for around 60%, had a diagnosis of hypertension for less than 5 years. The prevalence of concomitant conditions, such as cardiovascular disease or diabetes mellitus, was below 20% in both groups. The study also found no significant difference between the two groups in the proportion of having DLP and/or MAU with p = 0.999.
Table 3 indicates that three common lifestyle risk factors were prevalent in both study groups: low fruit and vegetable intake, high salt consumption, and low physical activity, with over 60% in all groups. The study found that most participants had uncontrolled blood pressure, with rates of 67.7% and 70.5% in the intervention and control groups, respectively. No significant differences were found between the two groups in terms of lifestyle-related risk factors, BMI control, treatment adherence, and blood pressure control.

3.2. Intervention Results

Table 4 illustrates the means and standard deviations of measurable outcomes before and after intervention. In terms of propotion, after the intervention, significant reductions in all dietary risk factors were observed in the intervention group (p < 0.001). Dissimilarly, a significant decrease was only noted in the consumption of fruits and vegetables (p < 0.001), while the others showed insignificant changes. The prevalence of high salt intake was significantly lower in the intervention group compared to the control group (p = 0.002, ARR = 16.9%, NNT = 6). However, there were no significant differences in the other dietary factors between the two groups (Table 5).
The intervention group showed significant reductions in smoking habits (p = 0.027) and low physical activity levels (p < 0.001) compared to baseline. However, no significant changes were observed in the control group for these factors. Furthermore, Table 4 shows that the disparity of low physical activity proportion was significant (p < 0.001, ARR = 21.9%, NNT = 5). However, there was no significant change in alcohol consumption and smoking habits between both groups after the intervention (p > 0.05).
Both groups showed significant improvements in achieving hypertension management targets, including BMI control (p < 0.001, p = 0.02), treatment adherence (p < 0.001, p = 0.01), and blood pressure control (p < 0.001, p = 0.02) at the endpoint (Table 6). Noticeably, the intervention group exhibited superior outcomes compared to the control group (BMI controlled: p = 0.024; treatment adherence: p < 0.001; BP control: p < 0.001). The study results demonstrated that independent interventions could reduce the prevalence of certain risk factors. The highest absolute risk reductions (ARRs) were observed for treatment non-adherence (ARR = 31.3%, NNT = 3), blood pressure control (ARR = 27.9%, NNT = 3), and low physical activity (ARR = 21.9%, NNT = 5). The ARR values in other risk factor groups ranged from 6.5% to 16.9%.
Regarding the DLP control goal, Table 7 shows that the intervention group had a higher chance of achieving the goals of managing these conditions compared to the control group (DLP: RR = 1.71, 95% CI: 1.12–2.7, p = 0.012). The independent health education intervention reduced the proportion of patients with DLP by 11.6% over 2 years, with an NNT of approximately nine patients. Likewise, the intervention group also demonstrated a greater likelihood of effectively managing MAU when compared to the control group (RR = 1.52, CI 95%, p = 0.007). ARR for microalbuminuria was 17.9% with an NNT of around six patients, respectively.
Table 8 shows that implementing health education activities over a span of 2 years can help reduce certain risky behaviors associated with hypertension and urinary protein levels. Among the risky behaviors, the cost to increase patient adherence to treatment and decrease low physical activity levels is the lowest, at USD 13 and USD 18, respectively. Notably, the cost to achieve blood pressure targets per patient is USD 15, which is lower than the cost to achieve targets for dyslipidemia and urinary protein levels, which is USD 34. Additionally, the Incremental Cost-Effectiveness Ratio (ICER) is highest for alcohol consumption and smoking habits, at USD 152 per behavior.

4. Discussion

The study utilized a quasi-experimental design with equivalent control and intervention groups in terms of sociodemographic characteristics, disease characteristics, and risk behaviors. This study’s strength lies in the similarity of the two groups, which was essential for evaluating the true effectiveness of the intervention on outcomes. Furthermore, this study design allowed for the use of ARR and NNT indices to assess intervention effectiveness, providing valuable evidence for policy makers to adjust health intervention strategies [21,22]. Future studies should evaluate the cost-effectiveness of additional health education to assess its benefits.
This study differs from previous studies in terms of the implementation of health education regarding the venue and health educator. Some previous studies utilized healthcare professionals such as public health experts, nurses, and physicians to conduct health education activities at healthcare facilities [23,24,25]. It can be observed that the effectiveness of health education may vary, partly depending on the capacity of the health educators. Previous studies assessed healthcare staff self-efficacy, but no comparisons were made between healthcare professionals and non-professionals [26]. In this study, health education activities were conducted by students. Utilizing trained non-professional healthcare personnel, such as volunteer students, in the intervention proved effective in achieving desired outcomes, highlighting the effectiveness of health education. Future studies should assess the capacity and availability of health educators, especially among non-professionals, to determine the sustainability of health education interventions.
In this study, the results showed that the additional health education intervention was statistically effective in reducing the salt intake rate. However, no significant differences were found in the rates of consuming fewer vegetables and consuming high-fat foods between the two groups after the intervention. Regarding salt intake, previous studies also demonstrated the effectiveness of health education interventions in reducing salt consumption [27,28]. Interestingly, the two risk behaviors of consuming fewer vegetables and consuming high-fat foods yielded contrasting results. The control group showed a significant decrease in vegetable consumption but no significant change in high-fat food intake. These results suggest that existing healthcare programs may be effective in promoting vegetable consumption but may not be enough to address the habit of consuming fried, fatty foods and high salt intake. Our results are different from a system review study which showed success in salt intake with various interventions and measurements [29]. The lack of effectiveness in reducing salt intake and the consumption of fried, fatty foods can be attributed to several factors. Firstly, variations in measurement methods across studies make it challenging to compare and evaluate the impact of interventions consistently [30,31]. Secondly, cultural cuisine and family eating habits, including the incorporation of fried vegetables and the use of fish sauce in Vietnamese meals, have a significant influence on dietary practices. For that reason, further studies should conduct experiments to understand the causes and propose solutions to minimize these two risk factors in hypertensive patients.
The intervention did not significantly impact the disparity in alcohol and tobacco use between the two groups after 2 years. Importantly, the rate of harmful alcohol consumption remained unchanged in both groups after the intervention. These results are not consistent with the study of Felicia W Chi, which achieved the objectives of reducing alcohol consumption [32,33]. These findings highlight the challenges of addressing addictive substances through health education, as it requires specialized skills and a supportive environment that may exceed the capabilities of the intervention groups [33,34]. Therefore, subsequent research on interventions aiming to reduce alcohol consumption and smoking in low-resource settings requires attention. By addressing challenges in low-resource settings, interventions can effectively promote behavior change and reduce alcohol- and smoking-related harms for hypertensive individuals.
When evaluating the effectiveness of the intervention in achieving outcomes such as BMI control, treatment adherence, and blood pressure control, the intervention group showed statistically significant differences in all three aspects. These results align with previous studies that have demonstrated improved effectiveness in reducing blood pressure or achieving blood pressure control [35,36,37]. Overall, the intervention in this study led to significant improvements in all outcome measures, successfully achieving the desired outcomes in hypertension treatment. These findings align with previous research highlighting the relationship between health literacy, BMI control, and hypertension control [38,39]. This serves as evidence for implementing additional community health education activities with non-professional resources which might enhance the outcomes of hypertensives with affordable resources.
Furthermore, the effectiveness of the intervention is further supported by the increased rate of DLP and MAU control in the intervention group. Previous studies have only shown the effectiveness of intervention in dyslipidemia when using medication or lifestyle modifications, but the rate remains low [17,40]. Regarding microalbuminuria management, our results are consistent with previous studies that highlight lifestyle factors as risk factors for microalbuminuria [41,42,43,44]. Our findings partly suggest a correlation between lifestyle improvement and the improvement in the microalbuminuria rate. The effectiveness of our study suggests the feasibility of community-based interventions after a 2-year period. Further studies should investigate the enablers and barriers to non-pharmacological interventions and consider the time required to achieve effectiveness.
The estimated ICER results suggest that health education has varying effectiveness for different outcomes. This difference indicates that health education programs should focus on behaviors that are modifiable and have lower costs. Risky behaviors such as smoking and alcohol consumption may require consideration of alternative indirect measures such as changes in pricing policies or taxes.

Limitations

The first limitation was that the potential bias introduced by our sampling process due to the unavoidable difference in geographic characteristics is acknowledged. To assess this bias, an analysis of the baseline characteristics was conducted between the intervention and control groups, revealing no significant differences. This indicates a minimal risk of bias in our study, although it cannot be excluded.
Secondly, in this study, the evaluator also functioned as the interventionist, which could have introduced subjectivity in assessing the changes in risk behaviors and other outcomes. However, implementing blind assessment using a separate team of investigators was not practically feasible as the enhanced health education activities would have been easily recognizable. To address potential bias in the evaluation process, the research team enhanced regular training activities and reinforced the honesty of the volunteers. Additionally, a good rapport with participants was established through home visits to foster open and honest responses. The decision not to use different individuals for data collection was made to maintain the established rapport and ensure reliable responses. Finally, in addition to subjective outcomes, we also measured objective outcomes such as automated blood pressure measurements, lipid profile tests, and microalbuminuria in both groups.
Another limitation of the study was that the outcomes were assessed as binary variables for continuous variables such as microalbuminuria and blood pressure control. This may reduce the accuracy in evaluating the true effectiveness of health education activities as seen in quantitative studies. However, this assessment was beneficial in calculating epidemiological indices such as ARR and NNT, which might be meaningful in policy decision-making. Future studies should consider describing both types of outcomes to provide more insights into community interventions. Moreover, further research should consider using strict time-to-event analysis to explore the impact of health education carefully.
The magnitude of the effectiveness of the health education program delivered by humans in primary care settings was not always consistent. Distinct reasons are subjective assessment and evaluation, inconsistent health education provided by different educators, and variations in the dose of education received by participants. To improve these interventions, solutions can be implemented. These include standardized assessment and evaluation, comprehensive training, quality assurance, a structured curriculum, technology integration, and fostering collaboration among educators. By implementing these solutions, health education interventions can address the limitations and ensure more standardized, effective, and equitable delivery of education to participants.

5. Conclusions

In conclusion, the management of hypertension requires a comprehensive approach that encompasses various aspects. This study highlights the effectiveness of additional health education by non-professional personnel in promoting healthier outcomes, including improved control of BMI, blood pressure, medication adherence, and management of dyslipidemia (DLP) and microalbuminuria (MAU). These findings support the integration of health education interventions in hypertension management programs. However, further research is needed to explore the full potential of health education in primary healthcare settings.

Author Contributions

Conceptualization: M.H.L. and T.K.N.; Methodology: T.T.P. (Thi Tam Pham), T.T.P. (Trung Tin Pham), and V.D.T.; Investigation: T.T.P. (Thi Tam Pham) and V.D.T.; Resources: M.H.L. and T.K.N.; Writing—original draft: T.T.P. (Trung Tin Pham) and V.D.T.; Writing—review and editing: M.H.L. and T.K.N. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was approved by the Medical Ethics Council of Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam (reference: 18/PCT-HĐĐĐ; date: 10 October 2016).

Informed Consent Statement

Participants were advised of the voluntary nature of their involvement, and survey responses were anonymized at the source. Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data that support the findings of this study are available from the corresponding authors V.D.T. and T.T.P. (Trung Tin Pham) upon reasonable request.

Acknowledgments

We would like to express our sincere gratitude to the staff from the Faculty of Pharmacy, Can Tho University of Medicine and Pharmacy, for their valuable contributions and support throughout the study. Additionally, we extend our appreciation to the Vinh Long Department of Health in Vinh Long, Vietnam, for granting authorization and helping with the study. Lastly, we are profoundly thankful to the patients and their families who participated in the study over the course of two years.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Blood Pressure/Hypertension. (n.d.). Available online: https://www.who.int/data/gho/indicator-metadata-registry/imr-details/3155 (accessed on 10 June 2023).
  2. Mills, K.T.; Bundy, J.D.; Kelly, T.N.; Reed, J.E.; Kearney, P.M.; Reynolds, K.; Chen, J.; He, J. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-based Studies from 90 Countries. Circulation 2016, 134, 441. [Google Scholar] [CrossRef] [PubMed]
  3. Van Minh, H.; Viet, N.L.; Sinh, C.T.; Hung, P.N.; Ngoc, N.T.M.; van Hung, N.; Son, T.K.; Dong, N.T.; Thang, D.C.; Thuan, N.D.; et al. May Measurement Month 2018: An analysis of blood pressure screening results from Vietnam. Eur. Heart J. Suppl. 2020, 22 (Suppl. H), H139–H141. [Google Scholar] [CrossRef] [PubMed]
  4. Verma, N.; Rastogi, S.; Chia, Y.C.; Siddique, S.; Turana, Y.; Cheng, H.m.; Sogunuru, G.P.; Tay, J.C.; Teo, B.W.; Wang, T.D.; et al. Non-pharmacological management of hypertension. J. Clin. Hypertens. 2021, 23, 1275. [Google Scholar] [CrossRef]
  5. Carey, R.M.; Moran, A.E.; Whelton, P.K. Treatment of Hypertension: A Review. JAMA 2022, 328, 1849–1861. [Google Scholar] [CrossRef]
  6. Cheung, B.M.Y.; Lam, T.C. Hypertension|Hypertension and Diet. In Encyclopedia of Food Sciences and Nutrition; Academic Press: Cambridge, MA, USA, 2003; pp. 3194–3199. [Google Scholar] [CrossRef]
  7. Jensen, J.S.; Feldt-Rasmussen, B.; Strandgaard, S.; Schroll, M.; Borch-Johnsen, K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000, 35, 898–903. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Krone, W.; Müller-Wieland, D. Hyperlipidaemia and hypertension. Bailliere’s Clin. Endocrinol. Metab. 1990, 4, 833–850. [Google Scholar] [CrossRef] [PubMed]
  9. Clebak, K.T.; Dambro, A.B. Hyperlipidemia: An Evidence-based Review of Current Guidelines. Cureus 2020, 12, e7326. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Ezeh, K.J.; Ezeudemba, O. Hyperlipidemia: A Review of the Novel Methods for the Management of Lipids. Cureus 2021, 13, e16412. [Google Scholar] [CrossRef] [PubMed]
  11. Knežević, T.; Gellineo, L.; Jelaković, A.; Premužić, V.; Dika, Ž.; Laganović, M.; Jelaković, B. Treatment of Hypertension Induced Albuminuria. Curr. Pharm. Des. 2018, 24, 4404–4412. [Google Scholar] [CrossRef]
  12. Kuritzky, L.; Toto, R.; Van Buren, P. Identification and Management of Albuminuria in the Primary Care Setting. J. Clin. Hypertens. 2011, 13, 438–449. [Google Scholar] [CrossRef] [PubMed]
  13. Bruno, C.M.; Amaradio, M.D.; Pricoco, G.; Marino, E.; Bruno, F. Lifestyle and Hypertension: An Evidence-Based Review. J. Hypertens. Manag. 2018, 4, 1–10. [Google Scholar] [CrossRef]
  14. Hanssen, H. Lifestyle recommendations as treatment for arterial hypertension: A time to review. Eur. J. Prev. Cardiol. 2023, 30, 95–97. [Google Scholar] [CrossRef] [PubMed]
  15. Hasandokht, T.; Farajzadegan, Z.; Siadat, Z.D.; Paknahad, Z.; Rajati, F. Lifestyle interventions for hypertension treatment among Iranian women in primary health-care settings: Results of a randomized controlled trial. J. Res. Med. Sci. 2015, 20, 54. [Google Scholar] [PubMed]
  16. Janse Van Rensburg, W.J. Lifestyle Change Alone Sufficient to Lower Cholesterol in Male Patient With Moderately Elevated Cholesterol: A Case Report. Am. J. Lifestyle Med. 2019, 13, 148. [Google Scholar] [CrossRef]
  17. Mannu, G.S.; Zaman, M.J.S.; Gupta, A.; Rehman, H.; Myint, P.K. Evidence of Lifestyle Modification in the Management of Hypercholesterolemia. Curr. Cardiol. Rev. 2013, 9, 2. [Google Scholar] [CrossRef] [Green Version]
  18. Meiqari, L.; Nguyen, T.P.L.; Essink, D.; Zweekhorst, M.; Wright, P.; Scheele, F. Access to hypertension care and services in primary health-care settings in Vietnam: A systematic narrative review of existing literature. Glob. Health Action 2019, 12, 1610253. [Google Scholar] [CrossRef] [Green Version]
  19. Mancia, G.; Fagard, R.; Narkiewicz, K.; Redon, J.; Zanchetti, A.; Böhm, M.; Christiaens, T.; Cifkova, R.; De Backer, G.; Dominiczak, A.; et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 2013, 34, 2159–2219. [Google Scholar] [CrossRef] [Green Version]
  20. Dettori, J.R. Loss to follow-up. Evid. Based Spine-Care J. 2011, 2, 7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. Cook, R.J.; Sackett, D.L. The number needed to treat: A clinically useful measure of treatment effect. BMJ 1995, 310, 452. [Google Scholar] [CrossRef] [Green Version]
  22. Mendes, D.; Alves, C.; Batel-Marques, F. Number needed to treat (NNT) in clinical literature: An appraisal. BMC Med. 2017, 15, 112. [Google Scholar] [CrossRef] [Green Version]
  23. Debela, D.B.; Dhaba, B.; Shumi, G.; Abagero, A.; Gudina, G.; Ayana, Y.; Addissie, A.; Deressa, W.; Scuteri, A. Effect of an Educational Intervention on Lifestyle Modification of Patients With Hypertension at Bishoftu General Hospital, Ethiopia, 2021. Prev. Chronic Dis. 2023, 20, E20. [Google Scholar] [CrossRef] [PubMed]
  24. Ho, T.M.; Estrada, D.; Agudo, J.; Arias, P.; Capillas, R.; Gibert, E.; Isnard, M.M.; Solé, M.J.; Salvadó, A. Assessing the impact of educational intervention in patients with hypertension. J. Ren. Care 2016, 42, 205–211. [Google Scholar] [CrossRef] [PubMed]
  25. Ozoemena, E.L.; Iweama, C.N.; Agbaje, O.S.; Umoke, P.C.I.; Ene, O.C.; Ofili, P.C.; Agu, B.N.; Orisa, C.U.; Agu, M.; Anthony, E. Effects of a health education intervention on hypertension-related knowledge, prevention and self-care practices in Nigerian retirees: A quasi-experimental study. Arch. Public Health 2019, 77, 1–16. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Nobiling, B.D.; Long-White, D.; Petrolino, A. Reported Self-Efficacy of Health Educators During COVID-19. INQUIRY J. Med. Care Organ. Provis. Financ. 2022, 59, 00469580221139140. [Google Scholar] [CrossRef] [PubMed]
  27. Trieu, K.; McMahon, E.; Santos, J.A.; Bauman, A.; Jolly, K.A.; Bolam, B.; Webster, J. Review of behaviour change interventions to reduce population salt intake. Int. J. Behav. Nutr. Phys. Act. 2017, 14, 1–15. [Google Scholar] [CrossRef] [Green Version]
  28. Zhou, B.; Carrillo-Larco, R.M.; Danaei, G.; Riley, L.M.; Paciorek, C.J.; Stevens, G.A.; Gregg, E.W.; Bennett, J.E.; Solomon, B.; Singleton, R.K.; et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 2021, 398, 957–980. [Google Scholar] [CrossRef] [PubMed]
  29. Silva-Santos, T.; Moreira, P.; Rodrigues, M.; Padrão, P.; Pinho, O.; Norton, P.; Ndrio, A.; Gonçalves, C. Interventions that successfully reduced adults salt intake—A systematic review. Nutrients 2022, 14, 6. [Google Scholar] [CrossRef] [PubMed]
  30. Almeida, V.; Seto, T.; Banna, J. Considerations for Measurement of Sodium Intake. Am. J. Lifestyle Med. 2020, 14, 585. [Google Scholar] [CrossRef]
  31. McLean, R.M. Measuring Population Sodium Intake: A Review of Methods. Nutrients 2014, 6, 4651. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Chi, F.W.; Parthasarathy, S.; Palzes, V.A.; Kline-Simon, A.H.; Weisner, C.M.; Satre, D.D.; Grant, R.W.; Elson, J.; Ross, T.B.; Awsare, S.; et al. Associations between alcohol brief intervention in primary care and drinking and health outcomes in adults with hypertension and type 2 diabetes: A population-based observational study. BMJ Open 2023, 13, e064088. [Google Scholar] [CrossRef] [PubMed]
  33. Ettner, S.L.; Xu, H.; Duru, O.K.; Ang, A.; Tseng, C.H.; Tallen, L.; Barnes, A.; Mirkin, M.; Ransohoff, K.; Moore, A.A. The Effect of an Educational Intervention on Alcohol Consumption, At-Risk Drinking, and Health Care Utilization in Older Adults: The Project SHARE Study. J. Stud. Alcohol Drugs 2014, 75, 447. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Khanal, M.K.; Bhandari, P.; Dhungana, R.R.; Bhandari, P.; Rawal, L.B.; Gurung, Y.; Paudel, K.N.; Singh, A.; Devkota, S.; de Courten, B. Effectiveness of community-based health education and home support program to reduce blood pressure among patients with uncontrolled hypertension in Nepal: A cluster-randomized trial. PLoS ONE 2021, 16, e0258406. [Google Scholar] [CrossRef]
  35. Golechha, M. Health Promotion Methods for Smoking Prevention and Cessation: A Comprehensive Review of Effectiveness and the Way Forward. Int. J. Prev. Med. 2016, 7, 7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Lu, C.H.; Tang, S.T.; Lei, Y.X.; Zhang, M.Q.; Lin, W.Q.; Ding, S.H.; Wang, P.X. Community-based interventions in hypertensive patients: A comparison of three health education strategies. BMC Public Health 2015, 15, 33. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Neupane, D.; McLachlan, C.S.; Mishra, S.R.; Olsen, M.H.; Perry, H.B.; Karki, A.; Kallestrup, P. Effectiveness of a lifestyle intervention led by female community health volunteers versus usual care in blood pressure reduction (COBIN): An open-label, cluster-randomised trial. Lancet Glob. Health 2018, 6, e66–e73. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Halladay, J.R.; Donahue, K.E.; Cené, C.W.; Li, Q.; Cummings, D.M.; Hinderliter, A.L.; Miller, C.L.; Garcia, B.A.; Little, E.; Rachide, M.; et al. The Association of Health Literacy and Blood Pressure Reduction in a Cohort of Patients with Hypertension: The Heart Healthy Lenoir Trial. Patient Educ. Couns. 2017, 100, 542. [Google Scholar] [CrossRef] [Green Version]
  39. Nguyen, T.T.; Nguyen, M.H.; Nguyen, Y.H.; Nguyen, T.T.P.; Giap, M.H.; Tran, T.D.X.; Pham, T.T.M.; Pham, K.M.; Nguyen, K.T.; Le, V.T.T.; et al. Body mass index, body fat percentage, and visceral fat as mediators in the association between health literacy and hypertension among residents living in rural and suburban areas. Front. Med. 2022, 9, 877013. [Google Scholar] [CrossRef] [PubMed]
  40. Jeemon, P.; Gupta, R.; Onen, C.; Adler, A.; Gaziano, T.; Prabhakaran, D.; Poulter, N. Management of Hypertension and Dyslipidemia for Primary Prevention of Cardiovascular Disease. In Disease Control Priorities; World Bank: Washington, DC, USA, 2017; pp. 389–404. [Google Scholar] [CrossRef]
  41. Abbafati, C.; Abbas, K.M.; Abbasi-Kangevari, M.; Abd-Allah, F.; Abdelalim, A.; Abdollahi, M.; Abdollahpour, I.; Abegaz, K.H.; Abolhassani, H.; Aboyans, V.; et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020, 396, 1223–1249. [Google Scholar] [CrossRef]
  42. Chang, A.; Van Horn, L.; Jacobs, D.R.; Liu, K.; Muntner, P.; Newsome, B.; Shoham, D.A.; Durazo-Arvizu, R.; Bibbins-Domingo, K.; Reis, J.; et al. Lifestyle-Related Factors, Obesity, and Incident Microalbuminuria: The CARDIA (Coronary Artery Risk Development in Young Adults) Study. Am. J. Kidney Dis. 2013, 62, 267. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Grupper, A.; Ehrenwald, M.; Schwartz, D.; Berliner, S.; Shashar, M.; Baruch, R.; Schwartz, I.F.; Rogowski, O.; Zeltser, D.; Shapira, I.; et al. Hypertension is associated with increased post-exercise albuminuria, which may be attenuated by an active lifestyle. J. Clin. Hypertens. 2019, 21, 1171–1179. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Wakasugi, M.; Kazama, J.; Narita, I.; Iseki, K.; Fujimoto, S.; Moriyama, T.; Yamagata, K.; Konta, T.; Tsuruya, K.; Asahi, K.; et al. Association between Overall Lifestyle Changes and the Incidence of Proteinuria: A Population-based, Cohort Study. Intern. Med. 2017, 56, 1475. [Google Scholar] [CrossRef] [Green Version]
Table 1. The sociodemographic characteristics of the two groups.
Table 1. The sociodemographic characteristics of the two groups.
CharacteristicIntervention GroupControl Groupp *
N%n%
GenderWoman9759.110462.70.514
Man6740.96237.3
Age<50 years84.984.80.871
50–59 years4426.83822.9
60–69 years7747.08350.0
≥70 years3521.33722.3
EthnicityKinh15997.016398.20.463
Other53.031.8
Educational levelUnder primary education3722.63621.70.934
Primary education6841.57444.6
Secondary school3219.53219.3
High school and higher2716.52414.5
* Chi-square test.
Table 2. The hypertension characteristics in the intervention and control groups.
Table 2. The hypertension characteristics in the intervention and control groups.
CharacteristicIntervention GroupControl Groupp *
n%N%
Duration of hypertension
<5 years9457.310663.90.330
5–9 years4527.43219.3
10–14 years159.11911.4
≥15 years106.195.4
Diabetes
Yes1911.61914.10.968
No14588.414788.9
Cardiovascular diseases
Yes2917.73118.70.815
No13582.313581.3
Dyslipidemia and Microalbuminuria
Dyslipidemia15896.316096.40.999
Microalbuminuria10262.210060.2
* Chi-square test.
Table 3. Secondary outcomes among two groups at baseline.
Table 3. Secondary outcomes among two groups at baseline.
TypesIntervention GroupControl Groupp *
n%n%
Risk behaviors/lifestyleLow vegetable consumption (<400 g/day)No159.12012.00.392
Yes14990.914688.0
High salt intake
(>3 days/week)
No5634.15633.70.937
Yes10865.911066.3
High consumption of fatty foods
(>3 days/week)
No10161.610160.80.890
Yes6338.46539.2
Alcohol consumptionYes2414.62515.10.913
No14085.414184.9
Smoking habitYes3823.23219.30.387
No12676.813480.7
Low physical activity levelNo6740.96639.80.839
Yes9759.110060.2
OutcomesBMI controlledYes9256.18551.20.373
No7243.98148.8
Treatment adherence (risk)Yes8350.68148.80.742
No8149.48551.2
Blood pressure controlled (outcome)Yes5332.34929.50.582
No11167.711770.5
* Chi-square test. BMI: Body mass index.
Table 4. Outcome measures before and after intervention.
Table 4. Outcome measures before and after intervention.
OutcomesIntervention (n = 164)
Control (n = 166)
Mean (SD)
BeforeAfter
BMIIntervention22.9 (3.09)22.38 (2.93)
Control22.89 (3.73)23.31 (2.61)
Systolic BPIntervention128.60 (14.67)128.60 (14.67)
Control141.16 (19.93)141.16 (19.93)
Diastolic BPIntervention77.3 (10.45)77.3 (10.45)
Control87.8 (11.51)87.8 (11.51)
Total cholesterolIntervention5.28 (1.25)5.28 (1.25)
Control5.68 (1.19)5.68 (1.19)
TriglycerideIntervention2.63 (1.49)2.63 (1.49)
Control2.82 (1.78)2.82 (1.78)
Low-density lipoprotein (LDL)Intervention2.83 (1.09)2.83 (1.09)
Control3.09 (1.04)3.09 (1.04)
High-density lipoprotein (HDL)Intervention1.25 (0.33)1.25 (0.33)
Control1.24 (0.25)1.24 (0.25)
MicroalbuminuriaIntervention72.73 (87.87)72.73 (87.87)
Control121.36 (74.18)121.36 (74.18)
Table 5. Effectiveness in dietary risk habits, substance use, and physical activity level.
Table 5. Effectiveness in dietary risk habits, substance use, and physical activity level.
OutcomesBeforeAfterp *p **ARR (%)NNT (People)
n%n%
Low vegetable consumption (<400 g/day)
Intervention
(n = 164)
No159.14728.70.144<0.001714
Yes14990.911771.3
Control
(n = 166)
No2012.03621.7 0.007
Yes14688.013078.3
High salt intake (≥3 days/week)
Intervention
(n = 164)
No5634.19256.10.002<0.00116.96
Yes10865.97243.9
Control
(n = 166)
No5633.76539.2 0.342
Yes11066.310160.8
High fried, fatty food consumption (≥3 days/week)
Intervention
(n = 164)
No10161.612576.20.0770.0018.3%12
Yes6338.43923.8
Control
(n = 166)
No10160.811267.5 0.200
Yes6539.25432.5
Alcohol consumption
Intervention
(n = 164)
Yes2414.61710.40.0850.1676.515
No14085.414789.6
Control
(n = 166)
Yes2515.12816.90.678
No14184.913883.1
Smoking habit
Intervention
(n = 164)
Yes3823.22716.50.7260.027−0.06-
No12676.813783.5
Control
(n = 166)
Yes3219.32515.1 0.065
No13480.714184.9
Low physical activity
Intervention
(n = 164)
Yes6740.910865.9<0.001<0.00121.95
No9759.15634.1
Control
(n = 166)
Yes6639.87344.00.419
No10060.29356.0
* Chi-square test; ** McNemar test. ARR: absolute risk reduction; NNT: number needed to treat (NNT).
Table 6. Effectiveness in BMI control, treatment adherence, and blood pressure control.
Table 6. Effectiveness in BMI control, treatment adherence, and blood pressure control.
OutcomesBeforeAfterp *p **ARR (%)NNT (People)
n%n%
BMI goal achieved
InterventionYes9256.112274.40.024<0.00113.67
No7243.94225.6
ControlYes8551.210160.80.002
No8148.86539.2
Treatment adherence
InterventionYes8350.615393.3<0.001<0.00131.33
No8149.4116.7
ControlYes8148.810362.00.010
No8551.26338.0
Blood pressure goal achieved
InterventionYes5332.311167.7<0.001<0.00127.93
No11167.75332.3
ControlYes4929.56639.80.030
No11770.510060.2
* Chi-square test; ** McNemar test. ARR: absolute risk reduction; NNT: number needed to treat (NNT).
Table 7. Effectiveness of interventions on blood lipid profile and microalbumin.
Table 7. Effectiveness of interventions on blood lipid profile and microalbumin.
GroupGoal AchievedRR
(CI 95%)
p *ARRNNT
YesNo
n%n%
Dyslipidemia
Intervention (n = 158)4327.211572.81.74
(1.12–2.70)
0.01211.69
Control (n = 160)2515.613584.4
Microalbuminuria
Intervention (n = 102)4544.15755.91.52
(1.09–2.12)
0.00717.96
Control (n = 103)2726.27673.8
* Chi-square test; RR: relative risk; CI: confidence interval; ARR: absolute risk reduction; NNT: number needed to treat (NNT).
Table 8. Incremental cost-effectiveness ratio.
Table 8. Incremental cost-effectiveness ratio.
Total Intervention Cost Difference between 2 Groups = 6627 USD in 2 Years
OutcomesAverage Intervention Cost (USD)Differences in Outcomes between 2 Groups (Patients)Incremental Cost-Effectiveness Ratio (ICER)
Low vegetable consumption6071638
High salt intake6072722
High fried, fatty food consumption6071347
Alcohol consumption6074152
Smoking habit6074152
Low physical activity6073418
BMI goal achieved6071443
Treatment adherence6074813
Blood pressure goal achieved6074115
Dyslipidemia goal achieved6071834
Microalbuminuria goal achieved6071834
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Le, M.H.; Nguyen, T.K.; Pham, T.T.; Pham, T.T.; Tran, V.D. Effectiveness of a Health Education Program in Hypertensive Patients with Dyslipidemia and/or Microalbuminuria: A Quasi-Experimental Study in Vinh Long Province, Vietnam. Healthcare 2023, 11, 2208. https://doi.org/10.3390/healthcare11152208

AMA Style

Le MH, Nguyen TK, Pham TT, Pham TT, Tran VD. Effectiveness of a Health Education Program in Hypertensive Patients with Dyslipidemia and/or Microalbuminuria: A Quasi-Experimental Study in Vinh Long Province, Vietnam. Healthcare. 2023; 11(15):2208. https://doi.org/10.3390/healthcare11152208

Chicago/Turabian Style

Le, Minh Huu, Trung Kien Nguyen, Thi Tam Pham, Trung Tin Pham, and Van De Tran. 2023. "Effectiveness of a Health Education Program in Hypertensive Patients with Dyslipidemia and/or Microalbuminuria: A Quasi-Experimental Study in Vinh Long Province, Vietnam" Healthcare 11, no. 15: 2208. https://doi.org/10.3390/healthcare11152208

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop